Long-term Outcome After Isolated Tricuspid Valve Repair
|ClinicalTrials.gov Identifier: NCT01537458|
Recruitment Status : Unknown
Verified February 2012 by Pieter De Meester, Universitaire Ziekenhuizen Leuven.
Recruitment status was: Not yet recruiting
First Posted : February 23, 2012
Last Update Posted : February 23, 2012
Tricuspid valve insufficiency (TI) is often noted on echocardiography. Although severe TI is known to cause significant morbidity and mortality, no good guidelines are available to guide intervention. Literature is mostly confined to tricuspid valve repair concomitant with mitral valve repair. Treatment options for isolated repair have not been investigated thoroughly.
The investigators want to evaluate retrospectively the outcome of isolated tricuspid valve repair, performed in our center. By doing this, the investigators want to evaluate predictors of outcome after repair.
|Condition or disease||Intervention/treatment|
|Tricuspid Valve Insufficiency||Procedure: follow-up of isolated tricuspid valve repair|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Study Start Date :||March 2012|
|Estimated Primary Completion Date :||June 2012|
Isolated TI repair
Patients that underwent isolated tricuspid valve repair
Procedure: follow-up of isolated tricuspid valve repair
follow-up of patients that underwent TV repair in the past.
- mortality [ Time Frame: 10 year ]
- Redo surgery [ Time Frame: 10 year ]
- functional capacity assessed by CPET [ Time Frame: 10 year ]
- Atrial fibrillation [ Time Frame: 10 year ]
- Hospitalisation [ Time Frame: 10 year ]hospitalisation for cardiovascular reasons
- Functional capacity assessed by NYHA functional class [ Time Frame: 10 years ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01537458
|Contact: Pieter De Meester, M.D.||firstname.lastname@example.org|
|University Hospitals Leuven||Not yet recruiting|
|Leuven, Vlaams-Brabant, Belgium, 3000|
|Contact: Pieter De Meester, M.D. email@example.com|
|Sub-Investigator: Pieter De Meester, M.D.|
|Principal Investigator: Werner Budts, M.D.; PhD|